| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
Departments of
* Veterans Affairs,
Cell Biology,
Medicine, and
# Plastic Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee;
Brown Cancer Center,
# Department of Pharmacology and Toxicology, University of Louisville, Louisville, Kentucky; and
|| Department of Medicine, UCLA School of Medicine, Los Angeles, CA
Correspondence: Ann Richmond, Ph.D., Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, TN 37232. E-mail: ann.richmond{at}mcmail.vanderbilt.edu
CXC chemokines, which induce angiogenesis, have glutamine-leucine-arginine amino acid residues (ELR motif) in the amino terminus and bind CXCR2 and the Duffy antigen chemokine-binding protein. Duffy, a seven transmembrane protein that binds CXC and CC chemokines, has not been shown to couple to trimeric G proteins or to transduce intracellular signals, although it is highly expressed on red blood cells, endothelial cells undergoing neovascularization, and neuronal cells. The binding of chemokines by Duffy could modulate chemokine responses positively or negatively. Positive regulation could come through the presentation of chemokine to functional receptors, and negative regulation could come through Duffy competition with functional chemokine receptors for chemokine binding, thus serving as a decoy receptor. To determine whether Duffy has a role in angiogenesis and/or maintenance of homeostasis, we developed transgenic mice expressing mDuffy under the control of the preproendothelin promoter/enhancer (PPEP), which directs expression of the transgene to the endothelium. Two PPEP-mDuffy-transgenic founders were identified, and expression of the transgene in the endothelium was verified by Northern blot, RT-PCR, and immunostaining of tissues. The phenotype of the mice carrying the transgene appeared normal by all visual parameters. However, careful comparison of transgenic and nontransgenic mice revealed two phenotypic differences: mDuffy-transgenic mice exhibited a diminished angiogenic response to MIP-2 in the corneal micropocket assay, and mDuffy-transgenic mice exhibited enhanced hepatocellular toxicity and necrosis as compared with nontransgenic littermates in response to overdose of acetaminophen (APAP; 400 mg/kg body weight). Morover, APAP treatment was lethal in 50% of the mDuffy-transgenic mice 24 h post challenge, and 100% of the nontransgenic littermates survived this treatment at the 24 h time point. Our data suggest that enhanced expression of mDuffy on endothelial cells can lead to impaired angiogenic response to chemokines and impaired maintenance of homeostasis in response to toxic stresses.
Key Words: hepatocellular toxicity • acetaminophen • chemotactic cytokines • MIP-2 • CXCR2
This article has been cited by other articles:
|
|
 |
|
  L. W. Horton, Y. Yu, S. Zaja-Milatovic, R. M. Strieter, and A. Richmond Opposing Roles of Murine Duffy Antigen Receptor for Chemokine and Murine CXC Chemokine Receptor-2 Receptors in Murine Melanoma Tumor Growth Cancer Res., October 15, 2007; 67(20): 9791 - 9799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shen, R. Schuster, K. F. Stringer, S. E. Waltz, and A. B. Lentsch The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth FASEB J, January 1, 2006; 20(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Heidemann, H. Ogawa, M. B. Dwinell, P. Rafiee, C. Maaser, H. R. Gockel, M. F. Otterson, D. M. Ota, N. Lugering, W. Domschke, et al. Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2 J. Biol. Chem., February 28, 2003; 278(10): 8508 - 8515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Lee, C. W. Frevert, D. R. Thorning, S. Segerer, C. E. Alpers, J.-P. Cartron, Y. Colin, V. A. Wong, T. R. Martin, and R. B. Goodman Enhanced Expression of Duffy Antigen in the Lungs During Suppurative Pneumonia J. Histochem. Cytochem., February 1, 2003; 51(2): 159 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Middleton, A. M. Patterson, L. Gardner, C. Schmutz, and B. A. Ashton Leukocyte extravasation: chemokine transport and presentation by the endothelium Blood, December 1, 2002; 100(12): 3853 - 3860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. LENTSCH The Duffy antigen/receptor for chemokines (DARC) and prostate cancer. A role as clear as black and white? FASEB J, July 1, 2002; 16(9): 1093 - 1095. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
